FOOD ADVISORY COMMITTEE and DIETARY SUPPLEMENTS SUBCOMMITTEE

 

GLUCOSAMINE AND CHONDROITIN SULFATE

AND OSTEOARTHRITIS

 

June 7-8, 2004

 

 

 

Briefing Materials - Table of Contents

 

 

Tab 1 – List of Attendees

 

Tab 2 – Meeting Agenda

 

Tab 3 – Petition Summaries

 

Tab 4 – FDA’s Tentative Conclusions

 

Tab 5 – Questions for Food Advisory Committee

 

Tab 6 – Appendix

 

Subtab 6 a -- Review Articles

i.                   Brandt, K.D. Animal models of osteoarthritis. Biorheology. 2002; 39(1-2):221-235.

ii.                 Felson, D.T., Lawrence, R.C., Dieppe, P.A., Hirsch, R., Helmick, C.G., Jordan, J.M., Kington, R.S., Lane, N.E., Nevitt, M.C., Zhang, Y., Sowers, M., McAlindon, T., Spector, T.D., Poole, A.R., Yanovski, S.Z., Ateshian, G., Sharma, L., Buckwalter, J.A., Brandt, K.D. and Fries, J.F. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000a; 133(8):635-646.

iii.              Felson, D.T., Lawrence, R.C., Hochberg, M.C., McAlindon, T., Dieppe, P.A., Minor, M.A., Blair, S.N., Berman, B.M., Fries, J.F., Weinberger, M., Lorig, K.R., Jacobs, J.J. and Goldberg, V. Osteoarthritis: new insights. Part 2: treatment approaches. Ann Intern Med. 2000b; 133(9):726-737.

 

Subtab 6 b – Petitions

                                                 i.      Weider Nutrition International, Inc. (petitioner A)

                                               ii.            Rotta Pharmaceutical, Inc. (petitioner B)